Want to see SKIN full AI Analyst Report?
SKIN Stock Chart & Stats
$0.91
-$0.07(-3.95%)
At close: 4:00 PM EST
$0.91
-$0.07(-3.95%)
Day’s Range― - ―
52-Week Range$0.55 - $2.69
Previous CloseN/A
Volume138.49K
Average Volume (3M)1.04M
Market Cap
$94.89M
Enterprise Value$279.72
Total Cash (Recent Filing)$204.40M
Total Debt (Recent Filing)$367.20M
Price to Earnings (P/E)―
Beta2.09
Next Earnings
Aug 06, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding129,600,040
10 Day Avg. Volume926,645
30 Day Avg. Volume1,036,656
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)2.88
Price to Sales (P/S)0.58
P/FCF Ratio4.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1.33Price Target Upside46.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.16
Revenue Forecast (FY)$290.47M
Bulls Say, Bears Say
Bulls Say
High Product-level Margins And EBITDASustained high adjusted margins (Q1 adjusted EBITDA margin 13.1% and adjusted gross margins above 70%) indicate strong unit economics and effective cost discipline. Durable margin structure supports reinvestment in R&D and marketing, and provides operating leverage as revenue stabilizes.
Growing Installed Base And Lower ChurnA growing installed base with sharply reduced churn underpins recurring consumables revenue and increases customer lifetime value. This durable customer footprint creates predictable repeat sales and supports margin resilience independent of near-term device placement volatility.
Positive Operating And Free Cash Flow Plus Strong Cash BalanceConsistent positive operating and free cash flow alongside a $204M cash balance gives the company runway to fund working capital, modest capex, and near-term obligations. Cash generation credibility improves ability to manage the balance sheet and invest in product initiatives.
Bears Say
Elevated Leverage And Modest Equity BaseVery high leverage and a small equity cushion constrain strategic flexibility, increase refinancing risk, and make the company sensitive to revenue or cash-flow misses. Large outstanding debt limits ability to pursue M&A or sizable R&D without improving deleveraging trends.
Revenue Decline And Softer Device PlacementsPersistent top-line weakness and falling device placements reduce the pipeline for future consumables sales and slow installed-base monetization. Declining revenue weakens operating leverage, complicates deleveraging, and raises execution demands on commercial fixes to restore growth.
Structural Macro And Competitive HeadwindsLonger purchase cycles, tighter credit and intensifying lower-cost competition are structural constraints on new device adoption and ASPs. These industry shifts can permanently slow capital-equipment sales and pressure margins unless the company further differentiates product and pricing models.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.55 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $94.89M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Aug 06, 2026 which is in 10 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.074 by $0.024.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.03.
How many shares outstanding does Beauty Health have?
Beauty Health has 129,600,040 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.074. Following the earnings report the stock price went down -36.264%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.33 (46.52% Upside)
$1.33 (46.52% Upside)
Blogger Sentiment
Bullish
SKIN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 319.9K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-29.77%
Trailing 12-Months
Company Description
Beauty Health
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Company Deck
SKIN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: operational and financial discipline produced a notable EBITDA beat, margin expansion, improved installed base metrics, and strong liquidity, but top-line performance remains pressured with declining sales, softer device placements, and structural macro/competitive headwinds. Management is taking concrete commercial and product actions and maintained EBITDA guidance while trimming revenue expectations, positioning 2026 as an execution/stabilization year with recovery expected in 2027.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$1.33
▲(46.52% Upside)
Technical Analysis
Ownership Overview
7.90% Insiders
11.12% Mutual Funds
17.71% Other Institutional Investors
60.17% Public Companies and
Individual Investors